Use of quantitative HIV RNA detection for early diagnosis of HIV infection in infants and acute HIV infections in Alberta, Canada

Journal of Clinical Microbiology

Volumn 50, Issue 2, 2012, Pages 502-505

  Lee, Bonita E ^a   Plitt, Sabrina S ^b   Jayaraman, Gayatri C ^c   Chui, Linda ^a,d   Singh, Ameeta E ^a   Preiksaitis, Jutta K ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d PROVINCIAL LABORATORY FOR PUBLIC HEALTH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ARTICLE; CANADA; DIAGNOSTIC TEST; EARLY DIAGNOSIS; ENZYME IMMUNOASSAY; FALSE POSITIVE RESULT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; NONHUMAN; NUCLEIC ACID ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; VIRUS LOAD; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALBERTA; CHILD, PRESCHOOL; DIAGNOSTIC ERRORS; EARLY DIAGNOSIS; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; VIRAL LOAD; YOUNG ADULT;

EID: 84862931025     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.05471-11     Document Type: Article

References (17)

1. Brambilla D, Granger S, Jennings C, Bremer J. 2001. Rates of falsepositive results on quantitative HIV RNA assays, p 112. Abstr. 8th Conf. Retrovir. Oppor. Infect.
2. Centers for Disease Control and Prevention. 2008. Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years - United States, 2008. MMWR Recommend. Rep. 57(RR-10):1-12.
3. Daar ES, et al. 2001. Diagnosis of primary HIV-1 infection. Los Angeles County Primary HIV Infection Recruitment Network. Ann. Intern. Med. 134:25-29.
4. Gray G, McIntyre J, Newell M-L. 2000. HIV-1 infection, p 232-257. In Newell ML, McIntyre J (ed), Congenital and perinatal infection: prevention, diagnosis and treatment. Cambridge University Press, Cambridge, United Kingdom.
5. Hecht FM, et al. 2002. Use of laboratory tests and clinical symptoms for identification of primary HIV infection. AIDS 16:1119 -1129.
6. Houston SC, Miedzinski LJ, Mashinter LD. 2002. Rapid progression of CD4 cell decline and subsequent response to salvage therapy in HIV-2 infection. AIDS 16:1189 -1191.
7. Kim JE, et al. 2007. Short communication: identification of a novel HIV type 1 subtype H/J recombinant in Canada with discordant HIV viral load (RNA) values in three different commercial assays. AIDS Res. Hum. Retroviruses 23:1309 -1313.
8. Kleinman SH, Lelie N, Busch MP. 2009. Infectivity of human immunodeficiency virus-1, hepatitisCvirus, and hepatitis B virus and risk of transmission by transfusion. Transfusion 49:2454 -2489.
9. Lindbäck S, et al. 2000. Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure. Karolinska Institute Primary HIV Infection Study Group. AIDS 14:2333-2339.
10. Nesheim S, et al. 2003. Quantitative RNA testing for diagnosis of HIV-infected infants. J. Acquir. Immune Defic. Syndr. 32:192-195. (Pubitemid 36222721)
11. Neumann PW, et al. 1989. Laboratory diagnosis of the first cases of HIV-2 infection in Canada. CMAJ 140:125-128. (Pubitemid 19043152)
12. Pierce VM, Neide B, Hodinka RL. 2011. Evaluation of the Gen-Probe Aptima HIV-1 RNA qualitative assay as an alternative to Western blot analysis for confirmation of HIV infection. J. Clin. Microbiol. 49:1642-1645.
13. Pincus JM, et al. 2003. Acute human immunodeficiency virus infection in patients presenting to an urban urgent care center. Clin. Infect. Dis. 37:1699-1704. (Pubitemid 37549959)
14. Public Health Agency of Canada. 2009. Case definitions for communicable diseases under national surveillance. Can. Commun. Dis. Rep. 35(Suppl 2):86-87. http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/09vol35/35s2/HIV-VIH-eng.php. Accessed 10 October 2011.
15. Read JS. 2007. Diagnosis of HIV-1 infection in children younger than 18 months in the United States. Pediatrics 120:e1547-e1562.
16. Swanson P, et al. 2005. Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT. J. Clin. Microbiol. 43:3860-3868. (Pubitemid 41129673)
17. Young NL, et al. 2000. Early diagnosis of HIV-1-infected infants in Thailand using RNA and DNA PCR assays sensitive to non-B subtypes. J. Acquir. Immune Defic. Syndr. 24:401-407.